Anecortave acetate
Anecortave acetate
Anecortave Acetate
Anecortave acetate is a synthetic corticosteroid derivative that has been investigated for its potential use in the treatment of ocular conditions, particularly those involving neovascularization. It is a derivative of cortisol and is chemically related to other corticosteroids, but it has been modified to reduce its glucocorticoid activity while retaining its anti-angiogenic properties.
Mechanism of Action
Anecortave acetate functions primarily as an anti-angiogenic agent. It inhibits the formation of new blood vessels, a process known as angiogenesis, which is a critical factor in the progression of several ocular diseases. The drug achieves this by interfering with the signaling pathways that promote the proliferation and migration of endothelial cells, which are essential for new blood vessel formation.
Clinical Applications
Anecortave acetate has been studied for its potential use in treating age-related macular degeneration (AMD), a leading cause of vision loss in the elderly. In AMD, abnormal blood vessels grow under the retina, leading to vision impairment. By inhibiting angiogenesis, anecortave acetate aims to prevent the progression of this condition.
Administration
The drug is typically administered as a periocular injection, which involves delivering the medication to the area surrounding the eye. This method allows for localized treatment, minimizing systemic exposure and potential side effects associated with corticosteroids.
Research and Development
While anecortave acetate showed promise in early clinical trials, subsequent studies yielded mixed results regarding its efficacy compared to other treatments, such as anti-VEGF therapies. As a result, its development has been limited, and it is not widely used in clinical practice.
Related Pages
| Mineralocorticoids and antimineralocorticoids (H02) | ||||||
|---|---|---|---|---|---|---|
|
This article is a ophthalmology stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD